Zhou Xiaoming, Ferraris Joan D, Dmitrieva Natalia I, Liu Yusen, Burg Maurice B
Division of Nephrology, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA.
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5620-5. doi: 10.1073/pnas.0801453105. Epub 2008 Mar 26.
High NaCl rapidly activates p38 MAPK by phosphorylating it, the phosphorylation presumably being regulated by a balance of kinases and phosphatases. Kinases are known, but the phosphatases are uncertain. Our initial purpose was to identify the phosphatases. We find that in HEK293 cells transient overexpression of MAPK phosphatase-1 (MKP-1), a dual-specificity phosphatase, inhibits high NaCl-induced phosphorylation of p38, and that overexpression of a dominant negative mutant of MKP-1 does the opposite. High NaCl lowers MKP-1 activity by increasing reactive oxygen species, which directly inhibit MKP-1, and by reducing binding of MKP-1 to p38. Because inhibition of p38 is reported to reduce hypertonicity-induced activation of the osmoprotective transcription factor, TonEBP/OREBP, we anticipated that MKP-1 expression might also. However, overexpression of MKP-1 has no significant effect on Ton EBP/OREBP activity. This paradox is explained by opposing effects of p38alpha and p38delta, both of which are activated by high NaCl and inhibited by MKP-1. Thus, we find that overexpression of p38alpha increases high NaCl-induced TonEBP/OREBP activity, but overexpression of p38delta reduces it. Also, siRNA-mediated knockdown of p38delta enhances the activation of TonEBP/OREBP. We conclude that high NaCl inhibits MKP-1, which contributes to the activation of p38. However, opposing actions of p38alpha and p38delta negate any effect on TonEBP/OREBP activity. Thus, activation of p38 isoforms by hypertonicity does not contribute to activation of TonEBP/OREBP because of opposing effects of p38alpha and p38delta, and effects of inhibitors of p38 depend on which isoform is affected, which can be misleading.
高浓度氯化钠通过磷酸化作用快速激活p38丝裂原活化蛋白激酶(p38 MAPK),这种磷酸化作用可能受激酶和磷酸酶平衡的调节。激酶已为人所知,但磷酸酶尚不确定。我们最初的目的是鉴定这些磷酸酶。我们发现,在人胚肾293(HEK293)细胞中瞬时过表达双特异性磷酸酶丝裂原活化蛋白激酶磷酸酶-1(MKP-1)可抑制高浓度氯化钠诱导的p38磷酸化,而过表达MKP-1的显性负性突变体则产生相反的效果。高浓度氯化钠通过增加活性氧直接抑制MKP-1,并减少MKP-1与p38的结合,从而降低MKP-1的活性。由于据报道抑制p38可减少高渗诱导的渗透保护转录因子TonEBP/OREBP的激活,我们预计MKP-1的表达可能也会如此。然而,MKP-1的过表达对TonEBP/OREBP的活性没有显著影响。这一矛盾现象可通过p38α和p38δ的相反作用来解释,二者均被高浓度氯化钠激活并被MKP-1抑制。因此,我们发现p38α的过表达会增加高浓度氯化钠诱导的TonEBP/OREBP活性,但p38δ的过表达则会降低该活性。此外,小干扰RNA(siRNA)介导的p38δ敲低增强了TonEBP/OREBP的激活。我们得出结论,高浓度氯化钠抑制MKP-1,这有助于p38的激活。然而,p38α和p38δ的相反作用抵消了对TonEBP/OREBP活性的任何影响。因此,由于p38α和p38δ的相反作用,高渗激活p38同工型并不会导致TonEBP/OREBP的激活,并且p38抑制剂的作用取决于受影响的同工型,这可能会产生误导。